Smith & Nephew plc (LON:SN)
989.00
+6.60 (0.67%)
Oct 2, 2026, 4:35 PM GMT
Smith & Nephew Revenue
Smith & Nephew had revenue of $3.10B USD in the half year ending June 27, 2026, with 9.55% growth. This brings the company's revenue in the last twelve months to $6.30B, up 5.99% year-over-year. In the year 2025, Smith & Nephew had annual revenue of $6.16B with 6.09% growth.
Revenue (ttm)
$6.30B
Revenue Growth
+5.99%
P/S Ratio
1.75
Revenue / Employee
$370.59K
Employees
17,000
Market Cap
8.32B GBP
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.16B | 354.00M | 6.09% |
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | 5.14B | 234.00M | 4.77% |
| Dec 31, 2018 | 4.90B | 139.00M | 2.92% |
| Dec 31, 2017 | 4.77B | 96.00M | 2.06% |
| Dec 31, 2016 | 4.67B | 35.00M | 0.76% |
| Dec 31, 2015 | 4.63B | 17.00M | 0.37% |
| Dec 31, 2014 | 4.62B | 266.00M | 6.11% |
| Dec 31, 2013 | 4.35B | 214.00M | 5.17% |
| Dec 31, 2012 | 4.14B | -133.00M | -3.11% |
| Dec 31, 2011 | 4.27B | 308.00M | 7.77% |
| Dec 31, 2010 | 3.96B | 190.00M | 5.04% |
| Dec 31, 2009 | 3.77B | -29.00M | -0.76% |
| Dec 31, 2008 | 3.80B | 432.00M | 12.82% |
| Dec 31, 2007 | 3.37B | 590.00M | 21.23% |
| Dec 31, 2006 | 2.78B | 227.00M | 8.89% |
| Dec 31, 2005 | 2.55B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AOTI, Inc. | 52.74M |
| EKF Diagnostics Holdings | 51.35M |
| Inspiration Healthcare Group | 47.55M |
| NIOX Group | 47.50M |
| Surgical Innovations Group | 11.48M |
| Creo Medical Group | 7.00M |
| RUA Life Sciences | 4.62M |
| Proteome Sciences | 3.77M |
Smith & Nephew News
- 3 days ago - Smith & Nephew removed from European Conviction List at Goldman Sachs - TheFly
- 11 days ago - MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management - Financial Post
- 11 days ago - MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management - GlobeNewsWire
- 11 days ago - Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management - Financial Post
- 11 days ago - Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management - GlobeNewsWire
- 12 days ago - Smith & Nephew receives 510k clearance from FDA, completes cases with LANDMARK - TheFly
- 13 days ago - Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026 - Financial Post
- 13 days ago - Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026 - GlobeNewsWire